metaMe Health has enlisted the aid of health tech company Indegene to launch its recently-approved prescription digital therapeutic (DTx) Regulora for irritable bowel syndrome in the US.
The digital health company got a green light from the FDA last November for Regulora – which delivers hypnotherapy through an Apple or Android smartphone – as a therapy for abdominal pain associated with all forms of IBS.
Hypnotherapy is a recognised approach to treating pain associated with IBS, which affects 10% to 15% of all adults in the US, but until now has only been available in person through highly specialised therapists, who are in short supply.